PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Handel & varor |
| Industri | Sällanköpsvaror |
Company announcement no. 10-2025
May 29, 2025
Audientes A/S ("Audientes" or the "Company"), CVR 36047631, announces its unaudited financial results for Q1 2025. The Company provides updates on progress in its key markets and on product development.
Operating Highlights
- E-commerce expansion in Europe: Signed and onboarded partners for pan-European Amazon rollout starting June 2025, with product availability targeted across 10 countries and online marketing of `Companion by Audientes'.
- Supporting MENA market entry: Supporting partner Audivista in driving marketing and commercial rollout and product registrations of Ven and Companion in Turkey and in countries across the MENA region and also Central Asia.
- Japan commercialization: Pursuing direct e-commerce listings on Amazon, Yahoo Shopping, and Rakuten, with social media marketing.
- India development: Continued partner discussions to agree new product and market development strategies using engagement models applied in Japan and China.
- Localized Companion in China: Prepared further deliveries of ZhiYinYou-branded Companion devices for the Chinese market.
- JV in China (ZhiYinYou Technology Ltd.): Progressing development of an updated, new Ven hearing aid for NMPA approval ("Chinese FDA"); a strategic step into the Chinese medical device market.
- Licensing and OEM model development: Platform-centric licensing strategy advanced with ZhiYinYou Technology Ltd. as first licensee. OEM dialogues also initiated in Japan and Europe for both white-labeling of existing products and co-development of new solutions, targeting commercial agreements from 2026 onward.
- Product development: Continued progress on next-gen Receiver-in-Canal (RIC) hearing aid effort, aligned with a partner-driven product creation and go-to-market strategy for India, China and other markets. Updated multi-platform smartphone app with availability planned also for HarmonyOS and HyperOS.
Financial highlights for Q1 2025
| TDKK | Q1 2025 | Q1 2024 | 2024 |
| Revenue | 80 | 15 | 630 |
| Other operating income | 227 | 214 | 1,068 |
| EBITDA | -1,607 | -1,316 | -5,379 |
| Profit/loss for the period | -3,011 | -2,601 | -10,733 |
| Cash and cash equivalents | 4 | 3 | 9 |
| Equity | 470 | 2,382 | 1,199 |
| Equity ratio (%) | 6.1% | 18.6% | 13.6% |
| Earnings per share (DKK) | -0.01 | -0.04 | -0.05 |
| No. of shares beginning of the period | 399,411,640 | 59,384,318 | 59,384,318 |
| No. of shares end of period | 577,920,721 | 69,384,318 | 399,411,640 |
| Average number of shares | 488,666,181 | 64,384,318 | 229,397,979 |
In April 2024, the nominal value per share was reduced from DKK 0.10 to DKK 0.01. At the same time, the nominal share capital was reduced by DKK 6,244,589, corresponding to 624,458,900 shares, each with a nominal value of DKK 0.01.
- Revenue performance: Product sales revenue at TDKK 80 in Q1 2025, not yet reflecting the commercial momentum being built across key markets.
- EBITDA: Negative EBITDA remained broadly in line with expectations, driven by increased investments in marketing, market entry activities, and investor relations.
- Capitalization efforts: In Q1, Audientes raised DKK 2.2 million through a combination of directed share issuance, loan and debt conversion, including DKK 1.8 million in convertible loans and various debt converted to equity, and DKK 0.4 million in cash proceeds. An additional DKK 0.5 million in convertible loan was converted to equity in Q2.
- Capital structure: As of Q1 2025, equity amounted to DKK 0.5 million. With more than 50% of the share capital lost, management remains confident in reestablishing equity through upcoming financing and future profitability.
- Financing strategy: The company is pursuing additional funding to support operations and growth, including a targeted corporate bond of up to DKK 15 million (EUR 2 million) on the Bulgarian BEAM market, expected to close in June 2025.
Financial calendar
The Company's financial calendar is unchanged, as follows:
| Date | Event |
| August 29, 2025 | Q2 / half-year 2025 reporting |
| November 21, 2025 | Q3 2025 reporting |
| February 24, 2026 | Q4 / end of year 2025 reporting |
For further information, please contact:
Steen Thygesen, CEO, Audientes A/S
Phone: +45 77 34 16 80
Email: st@audientes.com
About Audientes A/S
Audientes A/S is a Danish hearing technology company specializing in smart, self-fitting and affordable hearing aids, hearables, and hearing protection solutions. Our mission is to make high-quality hearing technology accessible to everyone - whether for hearing improvement, enhancement, or protection - across consumer, medical, and industrial sectors worldwide.
In addition to our own products, we are developing a licensing business based on our proprietary software and hearing technology platform. This allows third-party brands, OEMs and manufacturers to integrate our proven self-fitting and audio processing capabilities into their own hearing products and solutions, thereby expanding our global reach and revenue potential.
Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in Copenhagen, Denmark, with subsidiaries in Hyderabad, India, and in Tokyo, Japan. Audientes also holds a 40% stake in a joint venture with Shenzhen Hengtong Partner Co. Ltd. in China.
For more information, please visit our websites www.audientes.com, www.audientes.eu, www.audientes.co.jp, www.audientes.in, or follow us on our social media channels.